ODN 21595 (sodium)
ODN 21595 sodium is a Guanine-Modified TLR7 and TLR9 inhibitor. ODN 21595 sodium inhibits the release of IFN-α and IL-6 with no cytotoxic. ODN 21595 sodium reduces the expression of CD86 and HLA-DR. ODN 21595 sodium has the potential for the research of systemic lupus erythematosus (SLE) [1].
Product Specifications
UNSPSC
12352208
Target
Toll-like Receptor (TLR)
Type
Oligonucleotides
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/odn-21595-sodium.html
Solubility
10 mM in H2O
Smiles
[ODN21595(sodium)]
References & Citations
[1]Römmler F, et al. Guanine-modified inhibitory oligonucleotides efficiently impair TLR7- and TLR9-mediated immune responses of human immune cells. PLoS One. 2015 Feb 19;10 (2) :e0116703.
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
215520 50 µL
Adenosine A1 Receptor (ADORA1, A1 adenosine Receptor, A1ar, Adenosine A1 Receptor, Adenosine Receptor A1, ADO-A1 Receptor, RDC7) discontinued
Ask
View Details RC231180L3V 200 µL
C14orf80 (TEDC1) (NM_001198983) Human Tagged ORF Clone Lentiviral Particle
Ask
View Details